In individuals with insulin resistance (IR), the presence of high ApoB levels, combined with other dyslipidemic components such as elevated triglycerides (TGs) and reduced high-density lipoprotein cholesterol (HDL-C), significantly elevates the risk of atherosclerosis and related cardiovascular events [74]. The gene discussed is APOB; the disease is atherosclerosis.